Arrhythmogenesis of surgical atrial incisions and lesions in Maze procedure: insights from high-resolution mapping of atrial tachycardias
Europace · 08.02.2023 · 25 (1) · 137-145
DOI: 10.1093/europace/euac102 ↗Kurz gefasst
Kommentar in der Zeitschrift Europace, online erschienen am 19.07.2022. Verfasst von Wei Hu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Surgical Wound, Catheter Ablation, Tachycardia, Supraventricular, Atrial Fibrillation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Atrial tachycardias (ATs) frequently develop after a surgical Maze procedure. We aimed to elucidate the electrophysiologic mechanisms and their arrhythmogenic substrates of these ATs. Methods and results We retrospectively reviewed 20 patients (14 females, mean age of 55.5 ± 8.6 years) with post-Maze ATs who underwent high-resolution mapping at three institutions. The slow conduction areas, reentry circuits, voltage signals, complex electrograms, and their correlation with the surgical incisions and lesions placed in the surgical Maze procedures were analyzed. Thirty-six ATs with a mean cycle length of 260.0 ± 67.6 ms were mapped in these patients. Among them, 22 (61.1%) were anatomical macro-reentrant ATs (AMAT), 12 (33.3%) non-AMATs (localized ATs), and 2 (5.6%) focal ATs, respectively. Epicardial conduction bridges were observed in 6/20 (30.0%) patients and 7/36 (19.4%) ATs. Different arrhythmogenic substrates were identified in these ATs, including slow conduction regions within the previous lesion areas or between the incisions and anatomical structures, the prolonged activation pathways caused by the short lesions connecting the tricuspid annulus, and the circuits around the long incisions and/or lesions.
Conclusions
Reentry is the main mechanism of the post-Maze ATs. The pro-arrhythmic substrates are most likely caused by surgical incisions and lesions. The slow conduction regions and the protected channels yielded from these areas are the major arrhythmogenic factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Cardiology Department, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Cardiology Department, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
- School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing, China.
- Cardiology Department, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
ORCID-Profile: Minglong Chen
Zitieren
APA
Hu, W., Zhou, D., Ding, X., Yang, G., Liu, H., Wang, Z., Chen, H., Ju, W., Li, M., Zhang, F., Yang, J., Han, J., Wu, X., Qiu, Z., Zheng, L., & Chen, M. (2023). Arrhythmogenesis of surgical atrial incisions and lesions in Maze procedure: insights from high-resolution mapping of atrial tachycardias. Europace, 25(1), 137-145. https://doi.org/10.1093/europace/euac102
Vancouver
Hu W, Zhou D, Ding X, Yang G, Liu H, Wang Z, et al. Arrhythmogenesis of surgical atrial incisions and lesions in Maze procedure: insights from high-resolution mapping of atrial tachycardias. Europace. 2023;25(1):137-145. doi:10.1093/europace/euac102
BibTeX
@article{Hu2023,
author = {Hu, Wei and Zhou, Dongchen and Ding, Xiangwei and Yang, Gang and Liu, Hailei and Wang, Zidun and Chen, Hongwu and Ju, Weizu and Li, Mingfang and Zhang, Fengxiang and Yang, Jian and Han, Jie and Wu, Xianhao and Qiu, Zhaohui and Zheng, Liangrong and Chen, Minglong},
title = {Arrhythmogenesis of surgical atrial incisions and lesions in Maze procedure: insights from high-resolution mapping of atrial tachycardias},
journal = {Europace},
year = {2023},
volume = {25},
number = {1},
pages = {137--145},
doi = {10.1093/europace/euac102}
}
EUVIMED